spiperone has been researched along with s 33084 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cussac, D; Millan, MJ; Newman-Tancredi, A; Sezgin, L | 2 |
2 other study(ies) available for spiperone and s 33084
| Article | Year |
|---|---|
The novel antagonist, S33084, and GR218,231 interact selectively with cloned and native, rat dopamine D(3) receptors as compared with native, rat dopamine D(2) receptors.
Topics: Animals; Benzopyrans; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Antagonists; Olfactory Pathways; Oxazines; Pyrroles; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Spiperone; Sulfones; Tetrahydronaphthalenes | 2000 |
[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors.
Topics: Animals; Benzopyrans; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine Antagonists; Humans; Pyrroles; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Spiperone; Transfection; Tritium | 2000 |